Phase II study of i.v. vinflunine as second line in patients with metastatic breast cancer after anthracycline-taxane failure

被引：0
|
作者：
Fumoleau, P
Campone, M
Vorobiof, D
Casado, M
Ruff, P
Kei, SK
Cortes-Funes, H
Khalfallah, S
Caroff, I
Colin, C
机构：
[1] Ctr George Francois Leclerc, Dijon, France
[2] CRLC Nantes Atlantique, Ctr Rene Gauducheau, St Herblain, France
[3] Saridton Oncol Ctr, Johannesburg, South Africa
[4] Univ Witwatersrand, Johannesburg, South Africa
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp 12 Octubre, E-28041 Madrid, Spain
[7] Inst Salah Azaiz, Tunis, Tunisia
[8] Inst Rech Pierre Fabre, Boulogne, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
542
引用
收藏
页码：13S / 13S
页数：1
相关论文
共 50 条
  • [1] Phase II study of i.v. vinflunine (VFL) as third-line treatment of metastatic breast carcinoma after failure of anthracycline-/taxane-based chemotherapy.
    Fumoleau, P.
    Cortes-Funes, H.
    Chan, S.
    Taleb, A.
    Campone, M.
    Pouget, J. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S279 - S279
  • [2] Preliminary results of a phase II study of intravenous vinflunine as second line therapy in patients with metastatic breast cancer after anhracycline-taxane based regimen failure
    Campone, M
    Vorobiof, D
    Cotes-Funes, H
    Verrill, M
    Khoo, KS
    Slabber, CF
    Caroff, I
    Pourget, JC
    Fumoleau, P
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S85 - S85
  • [3] A phase I/II study of oral capecitabine (X) and vinorelbine (V) as second- or -third line chemotherapy in anthracycline/taxane pretreated patients (pts) with metastatic breast cancer (MBC).
    Kellokumpu-Lehtinen, P
    Sjoström, J
    Sunela, K
    Lehtinen, I
    Joensuu, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S70 - S70
  • [4] Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy
    Fumoleau, Pierre
    Cortes-Funes, Hernan
    Taleb, Amina B.
    Chan, Stephen
    Campone, Mario
    Pouget, Jean-Christophe
    Tubiana-Hulin, Michele
    Slabber, Conrad F.
    Caroff-Paraiso, Isabelle
    Alberts, Albert S.
    Ben Ayed, Farhat
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (04): : 375 - 380
  • [5] Phase II study of irinotecan plus capecitabine in patients with anthracycline and taxane pretreated metastatic breast cancer
    Lee, K. S.
    Ro, J.
    Park, I. H.
    Kim, E. A.
    Nam, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase II Study of Gemcitabine Monotherapy as a Salvage Treatment for Japanese Metastatic Breast Cancer Patients after Anthracycline and Taxane Treatment
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    Fujiwara, Yasuhiro
    Iwata, Hiroji
    Sasaki, Yasutsuna
    Saji, Shigehira
    Aogi, Kenjiro
    Nambu, Yoshihiro
    Suri, Ajit
    Saeki, Toshiaki
    Takashima, Shigemitsu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (11) : 699 - 706
  • [7] Second line chemotherapy with 5 Fluorouracil and Vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer
    Razis, E
    Kosmidis, P
    Aravantinos, G
    Bakoyiannis, C
    Janinis, J
    Timotheadou, H
    Christodoulou, C
    Fountzilas, G
    CANCER INVESTIGATION, 2004, 22 (01) : 10 - 15
  • [8] Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
    M Campone
    H Cortes-Funes
    D Vorobiof
    M Martin
    C F Slabber
    E Ciruelos
    E Bourbouloux
    C Mendiola
    F M Delgado
    C Colin
    V Aslanis
    P Fumoleau
    British Journal of Cancer, 2006, 95 : 1161 - 1166
  • [9] Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
    Campone, M.
    Cortes-Funes, H.
    Vorobiof, D.
    Martin, M.
    Slabber, C. F.
    Ciruelos, E.
    Bourbouloux, E.
    Mendiola, C.
    Delgado, F. M.
    Colin, C.
    Aslanis, V.
    Fumoleau, P.
    BRITISH JOURNAL OF CANCER, 2006, 95 (09) : 1161 - 1166
  • [10] Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane
    C.H. Smorenburg
    M. Bontenbal
    C. Seynaeve
    C. van Zuylen
    G. de Heus
    J. Verweij
    R. de Wit
    Breast Cancer Research and Treatment, 2001, 66 : 83 - 87
12345